Forge Biologics’ Chief Executive Officer, Timothy J. Miller, Ph.D., will step down following almost five years of leadership at the Company he co-founded in 2020. John Maslowski, Forge’s Chief Commercial Officer, has been appointed as President, CEO, and a member of the Board of Directors, effective October 1, 2024.   Over the course of nearly five years, Miller led Forge’s transition from an early-stage venture-backed start-up through late-stage financings, and, most recently, a $620 million ...